Novel approach for treatment of Parkinson's disease
Lario Therapeutics awarded $6M Grant from The Michael J. Fox Foundation for Parkinson’s Research
Biotechnology
Founded in 2022, AlgenScribe SAS is actively crafting a genome editing framework tailored for Human Health encompassing therapeutics, bioproduction, research tools and diagnostics. AlgenScribe's objective is to unlock the complete potential of genome editing, focused on eliminating obstacles that ...
View start-upHealthcare
TRiCares is a dedicated medical device company located in Paris, France and Munich, Germany having the vision of bringing to the market a transfemoral tricuspid valve replacement system (TTVR). This TTVR system aims at helping patients suffering from severe tricuspid regurgitation (TR) without ...
View start-upBiotechnology
Draupnir Bio is a spin out company, from Aarhus University, Denmark and the Max-Planck Society, Germany. Backed by a syndicate of leading European investors – Gilde Healthcare Partners, Inkef Capital, Novo Seeds and MP Healthcare Venture Management – Draupnir is based in Copenhagen, with research ...
View start-up© 1997-2024 LUMITOS AG, All rights reserved